The American Society of Plastic Surgeons tracks cosmetic procedure statistics annually. The data reveals two simultaneous trends that, taken together, describe a convergence. Among women, the fastest-growing facial procedures include jawline contouring, chin augmentation, and buccal fat removal — procedures that create angular definition, sharpen the mandibular line, and reduce the soft-tissue fullness that characterizes the traditionally feminine face. Among men, the fastest-growing procedures include Botox (with male botulinum toxin procedures increasing substantially over the past decade), lip enhancement, and skin resurfacing — procedures that soften features, reduce ruggedness, and create the smoother surface texture traditionally associated with feminine aesthetics.
The overall pattern in ASPS data shows that male patients accounted for approximately 6% of all cosmetic procedures in the United States in 2023, with 82% of male procedures being non-surgical — predominantly Botox, fillers, and skin treatments that soften and smooth rather than sharpen or define. Among female patients, surgical procedures that enhance angularity — rhinoplasty (which increased 6% in a single year), jawline procedures, and facial contouring — are growing at rates that outpace traditional feminization procedures. The convergence is not theoretical. It is visible in the aggregate surgical data.
The American Academy of Facial Plastic and Reconstructive Surgery's 2024 annual trends survey reported that 92% of member surgeons saw male patients in their practice — a figure that would have been inconceivable in the 1990s, when male cosmetic surgery was a statistical footnote. The procedures men seek are not traditionally male. They seek smoother skin, fewer wrinkles, fuller lips, and refined features — the same features the beauty standard machine has distributed through celebrity culture and social media as universally aspirational, regardless of gender.
The convergence is also visible in non-surgical trends. The global facial injectable market — valued at $12.5 billion in 2024 — serves both genders with the same fundamental products: botulinum toxin for wrinkle reduction, hyaluronic acid fillers for volume and contour. The products are gender-neutral. The aesthetic outcomes they produce trend toward a shared template: smooth, symmetrical, defined but not extreme, youthful but not juvenile. This is not the template of either traditional masculinity or traditional femininity. It is the template of the beauty standard machine's optimized output.